Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up
MR

MRK

Market Closed

Merck & Co., Inc.

NYSEHealthcareDrug Manufacturers - General
US
73.00K employees
CEO: Robert Davis
Founded: 1978
$113.87
+$0.00(+NaN%)
Market Cap
281.24B
Beta
0.22
52W Range
N/A
Dividend Yield
2.95%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
72.0%
-4.6%
CAGR: 7.4%

Profit after direct costs

Operating Margin
36.2%
16.1%
CAGR: 15.5%

Core business profitability

Net Margin
28.1%
6.6%
CAGR: 8.8%

Bottom line profitability

Revenue Growth
1.2%
YoY
CAGR: 7.5%

Top line growth rate

Revenue Flow Analysis
Visual flow showing how MRK allocates revenue across expenses and profit
Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin
72.0%
$46.73B
Operating Margin
36.2%
$23.49B
Net Margin
28.1%
$18.25B
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
ItemTrend20212022202320242025YoY Change
Total Revenue
48.70B59.28B60.12B64.17B64.93B1.2%
Cost of Revenue
(13.63B)(17.41B)(16.13B)(15.19B)(18.20B)19.8%
Gross Profit
35.08B41.87B43.99B48.98B46.73B-4.6%
Operating Expenses
Research & Development
(12.24B)(13.55B)(30.53B)(17.94B)(12.51B)-30.2%
Selling, General & Administrative
(9.40B)(9.67B)(9.88B)(10.10B)(10.73B)6.2%
Depreciation & Amortization
(3.21B)(3.91B)(3.87B)(4.50B)(5.84B)29.8%
Operating Income (EBIT)
13.20B18.28B2.95B20.22B23.49B16.1%
Non-Operating Items
Interest Income
36.00M157.00M365.00M415.00M343.00M-17.3%
Interest Expense
(806.00M)(962.00M)(1.15B)(1.27B)(1.36B)6.8%
Other Income/Expenses (Net)
680.00M-1.84B-1.06B-285.00M-2.42B748.8%
Income Before Tax
13.88B16.44B1.89B19.94B21.07B5.7%
Income Tax Expense
(1.52B)(1.92B)(1.51B)(2.80B)(2.80B)0.0%
Net Income
13.05B14.52B365.00M17.12B18.25B6.6%
Per Share Metrics
Earnings Per Share (Basic)
$5$6$0$7$78.0%
Weighted Avg Shares Outstanding
2.53B2.53B2.61B2.53B2.50B-1.2%
Weighted Avg Shares Outstanding (Diluted)
2.54B2.54B2.55B2.54B2.51B-1.3%
EBITDA
17.90B21.32B6.91B25.71B28.26B9.9%

Explore MRK

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

MRK in the Healthcare

Mega Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms